cual es mejor tirzepatide o semaglutide Semaglutida y tirzepatida se consolidan como fármacos de elección contra la obesidad Cómo Ozempic, Wegovy, Mounjaro y

What they found: Favorable safety profile , no serious adverse events at doses up to 100 g/kg Preliminary efficacy signals positive The program stopped before Phase 3 for unknown commercial reasons (the program passed through several sponsor rotations and no one ultimately carried it through) Why it matters: These are the only published clinical data in humans that we have

Signs you may need a higher dose If you have been on 5mg for at least 4 weeks and experience minimal appetite suppression, no meaningful weight change, and no gastrointestinal side effects at all, your body may require a higher dose to achieve therapeutic levels

doi: 10.1016/j.cmet.2020.10.011 19

Dose-dependent effect: Gastrointestinal side effects, including diarrhea, are generally dose-dependent, meaning the higher the dose, the more likely you are to experience them